Urinary 5α-androstanediol and 5β-androstanediol measurement by gas chromatography after solid-phase extraction and high-performance liquid chromatography

International Journal of Biological Markers

Volumn 14, Issue 3, 1999, Pages 154-159

  Minut, G J ^a   Cambie M ^a   Lanzoni, M ^a   Marubini, E ^a,b   Secreto, G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

5 androstanze 3 ,17 diol,5 androstane 3 ,17 diol; Androgens; Breast cancer; Idiopathic measurement; Urinary measurement

Indexed keywords

ANDROSTANEDIOL; BIOLOGICAL MARKER; REAGENT; TESTOSTERONE;

ANALYTIC METHOD; ARTICLE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIRSUTISM; HORMONE DETERMINATION; HORMONE URINE LEVEL; SOLID PHASE EXTRACTION; TESTOSTERONE BLOOD LEVEL;

EID: 0032698863     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460089901400306     Document Type: Article

References (26)

1. Mauvais-Jarvis P, Baulieu EE. Studies on testosterone metabolism. IV. Urinary 5α- and β-androstanediols and testosterone glucuronide from testosterone and dehydroisoandrosterone sulfate in normal people and hirsute women. J Clin Endocrinol 1965; 25: 1167-78.
2. Berthou FL, Bardou LG, Floch HH. Measurement of 5α-androstane-3α,17β-diol and 5β-androstane-3α,17β-diol in the urine of healthy men and women. J Steroid Biochem 1971; 2: 141-53.
3. Mauvais-Jarvis P, Charransol G, Bobas-Masson F. Simultaneous determination of urinary androstanediol and tes-tosterone as an evaluation of human androgenicity. J Clin Endocrinol Metab 1973; 36: 452-9.
4. Deslypere JP, Sayed A, Punjabi U, Verdonck L, Vermeulen A. Plasma 5α-androstane-3α, 17β-diol and urinary 5α-androstane-3α, 17β-diol glucuronide, parameters of peripheral androgen action: a comparative study. J Clin Endocrinol Metab 1982; 54: 386-91.
5. Kuttenn F. Mowszowicz I, Schaison G, Mauvais-Jarvis P. Androgen production and skin metabolism in hirsutism. J Endocrinol 1977; 75: 83-91.
6. Genazzani AR, Pecciarini-Snickars L, Franchi F, De Leo V, Picciolini E, Tarascio P. Diagnostic approach to the hirsute patient. Horm Res 1978; 9: 379-93.
7. Secreto G, Zumoff B. Abnormal production of androgens in women with breast cancer. Anticancer Res 1994; 14: 2113-8.
8. Berrino F, Muti P, Micheli A, et al. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 1996; 88: 291-6.
9. Dorgan JF, Longcope C, Stephenson ME Jr, et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev 1996; 5: 533-9.
10. Zeleniuch-Jacquotte A, Bruning PF, Bonfrer JM, et al. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in post-menopausal women. Am J Epidemiol 1997; 145: 1030-8.
11. Thomas HV, Key TJ, Allen DS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br J Cancer 1997; 76: 401-5.
12. Venturelli E, Cavalleri A, Secreto G. Methods for urinary testosterone analysis. J Chromatogr B Biomed Appl 1995; 671: 363-80.
13. Venturelli E, Manzari A, Cavalleri A, Benzo M, Secreto G, Marubini E. Urinary testosterone measurement by gas chromatography after solid-phase extraction and high-performance liquid chromatography. J Chromatogr B Biomed Appl 1992; 582: 7-12.
14. Draper NR, Smith H. Applied regression analysis. New York: Wiley, 1981.
15. Hald A. Statistical theory with engineering applications. New York: Wiley, 1952.
16. Grattarola R. Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast. Cancer Res 1978; 38: 3051-4.
17. Secreto G, Fariselli G, Recchione C, Dati V, Di Pietro S. Androgen excretion in women with family history of breast cancer or with epithelial hyperplasia or cancer of the breast. Eur J Cancer Clin Oncol 1983; 19: 5-10.
18. Grattarola R. Androgens in breast cancer. I. Atypical endometrial hyperplasia and breast cancer in married premenopausal women. Am J Obstet Gynecol 1973; 116: 423-8.
19. Grattarola R, Secreto G, Recchione C, Castellini W. Androgens in breast cancer. II. Endometrial adenocarcinoma and breast cancer in married postmenopausal women. Am J Obstet Gynecol 1974; 118: 173-8.
20. Grattarola R, Secreto G, Recchione C. Androgens in breast cancer. III. Breast cancer recurrences years after mastectomy and increased androgenic activity. Am J Obstet Gynecol 1975; 121: 169-72.
21. Secreto G, Toniolo P, Berrino F, et al. Increased androgenic activity and breast cancer risk in premenopausal women. Cancer Res 1984; 44: 5902-5.
22. Secreto G, Toniolo P, Berrino F, et al. Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res 1991; 51: 2572-6.
23. Shackleton CHL, Roitman E, Phillips A, Chang T. Androstanediol and 5-androstenediol profiling for detecting exogenously administered dihydrotestosterone, epitestosterone, and dehydroepiandrosterone: Potential use in gas chromatography isotope ratio mass spectrometry. Steroids 1997; 62: 665-73.
24. Berthou F, Bardou L, Floch HH. Separation of urinary androstanediol and pregnanediol isomers by a combined gas-liquid chromatography-thin layer chromatography method. J Chromatogr 1974; 93: 149-65.
25. Mauvais-Jarvis P, Guillemant S, Corvol P, Floch HH, Bardou L. Metabolism of radioactive 5α-androstane-3β, 17β-diol. Steroids 1970; 16 (2): 173-81.
26. Snyder LR, Glajch JL, Kirkland JJ. Practical HPLC method development. New York: Wiley, 1988.